학술논문
P674: 2ND-LINE PONATINIB IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML-CP) PATIENTS FAILING OR INTOLERANT TO 1ST-LINE 2ND GENERATION TKI THERAPY: INTERIM ANALYSIS OF THE PROSPECTIVE PONS TRIAL
Document Type
article
Author
Source
HemaSphere, Vol 7, p e1679700 (2023)
Subject
Language
English
ISSN
2572-9241